329 related articles for article (PubMed ID: 22543015)
1. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic complications and anti-Alzheimer activities of sophoflavescenol, a prenylated flavonol from Sophora flavescens, and its structure-activity relationship.
Jung HA; Jin SE; Park JS; Choi JS
Phytother Res; 2011 May; 25(5):709-15. PubMed ID: 21077260
[TBL] [Abstract][Full Text] [Related]
4. Artificial neural network-based drug design for diabetes mellitus using flavonoids.
Patra JC; Chua BH
J Comput Chem; 2011 Mar; 32(4):555-67. PubMed ID: 20806262
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
Jung HA; Yoon NY; Kang SS; Kim YS; Choi JS
J Pharm Pharmacol; 2008 Sep; 60(9):1227-36. PubMed ID: 18718128
[TBL] [Abstract][Full Text] [Related]
6. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
[TBL] [Abstract][Full Text] [Related]
7. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and molecular docking studies of loganin and 7-O-galloyl-D-sedoheptulose from Corni Fructus as therapeutic agents for diabetic complications through inhibition of aldose reductase.
Lee CM; Jung HA; Oh SH; Park CH; Tanaka T; Yokozawa T; Choi JS
Arch Pharm Res; 2015 Jun; 38(6):1090-8. PubMed ID: 25315636
[TBL] [Abstract][Full Text] [Related]
9. 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase.
Chen X; Zhang S; Yang Y; Hussain S; He M; Gui D; Ma B; Jing C; Qiao Z; Zhu C; Yu Q
Bioorg Med Chem; 2011 Dec; 19(23):7262-9. PubMed ID: 22036211
[TBL] [Abstract][Full Text] [Related]
10. Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.
El-Kabbani O; Darmanin C; Schneider TR; Hazemann I; Ruiz F; Oka M; Joachimiak A; Schulze-Briese C; Tomizaki T; Mitschler A; Podjarny A
Proteins; 2004 Jun; 55(4):805-13. PubMed ID: 15146479
[TBL] [Abstract][Full Text] [Related]
11. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.
Steuber H; Heine A; Klebe G
J Mol Biol; 2007 May; 368(3):618-38. PubMed ID: 17368668
[TBL] [Abstract][Full Text] [Related]
12. Artificial neural networks-based approach to design ARIs using QSAR for diabetes mellitus.
Patra JC; Singh O
J Comput Chem; 2009 Nov; 30(15):2494-508. PubMed ID: 19373836
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic inhibition of non-enzymatic glycation and aldose reductase activity by naringenin: Binding, enzyme kinetics and molecular docking analysis.
Khan MS; Qais FA; Rehman MT; Ismail MH; Alokail MS; Altwaijry N; Alafaleq NO; AlAjmi MF; Salem N; Alqhatani R
Int J Biol Macromol; 2020 Sep; 159():87-97. PubMed ID: 32437808
[TBL] [Abstract][Full Text] [Related]
14. Identification of flavonoids and flavonoid rhamnosides from Rhododendron mucronulatum for. albiflorum and their inhibitory activities against aldose reductase.
Mok SY; Lee S
Food Chem; 2013 Jan; 136(2):969-74. PubMed ID: 23122151
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
16. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
Sotriffer CA; Krämer O; Klebe G
Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P
Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds.
Caballero J
J Mol Graph Model; 2010 Nov; 29(3):363-71. PubMed ID: 20863730
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening for inhibitors of human aldose reductase.
Kraemer O; Hazemann I; Podjarny AD; Klebe G
Proteins; 2004 Jun; 55(4):814-23. PubMed ID: 15146480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
